|
Market Cap (2-Jul) $75,017,136 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 21 October 2021, 8:18. The announcement is not marked as price sensitive, and is 21 page(s) in length and 2.12MB in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 1.052% short sold according to ASIC data. It was ranked the 177th most shorted stock on the ASX. It remains ranked 278th as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Investor Presentation | 21 October 2021, 8:18 |
| PREVENT Trial Successful, Statistically Significant Results | 19 October 2021, 11:02 |
| ImpediMed Investor Conference Call Notification | 19 October 2021, 10:18 |
| Trading Halt | 19 October 2021, 8:47 |
You must be logged in to post a reply.
ImpediMed 